Clinical trials
Phase 3 Leukemia, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Completed | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Acerta Pharma BV | 1 |
| AstraZeneca | 1 |
| German CLL Study Group | 1 |
| Loxo Oncology, Inc. | 1 |
| Newave Pharmaceutical Inc | 1 |
| Semmelweis University | 1 |
| University of Liverpool | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 10 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Leukemia | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
| Hematologic Diseases | 1 |
| Leukemia, Lymphoid | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.